title: Response to comment on Hong et al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes care 2013;36:1304-1311.
authors.affiliation: Corresponding author: Guang Ning, guangning@medmail.com.cn.
authors.forename: Jie
authors.initials: J
authors.lastname: Hong
authors.forename: Yifei
authors.initials: Y
authors.lastname: Zhang
authors.forename: Shenghan
authors.initials: S
authors.lastname: Lai
authors.forename: Guang
authors.initials: G
authors.lastname: Ning
mesh_terms: D003324:Coronary Artery Disease / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005260:Female; D005913:Glipizide / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008687:Metformin / Q000627:therapeutic use*
chemical_list: D008687:Metformin; D005913:Glipizide